Abstract
Alzheimer’s disease (AD) is a polygenic multifactorial neurodegenerative disease that, after decades of research and development, is still without a cure. There are some symptomatic treatments to manage the psychological symptoms but none of these drugs can halt disease progression. Additionally, over the last few years, many anti-AD drugs failed in late stages of clinical trials and many hypotheses surfaced to explain these failures, including the lack of clear understanding of disease pathways and processes. Recently, different epigenetic factors have been implicated in AD pathogenesis; thus, they could serve as promising AD diagnostic biomarkers. Additionally, network biology approaches have been suggested as effective tools to study AD on the systems level and discover multi-target-directed ligands as novel treatments for AD. Herein, we provide a comprehensive review on Alzheimer’s disease pathophysiology to provide a better understanding of disease pathogenesis hypotheses and decipher the role of genetic and epigenetic factors in disease development and progression. We also provide an overview of disease biomarkers and drug targets and suggest network biology approaches as new tools for identifying novel biomarkers and drugs. We also posit that the application of machine learning and artificial intelligence to mining Alzheimer’s disease multi-omics data will facilitate drug and biomarker discovery efforts and lead to effective individualized anti-Alzheimer treatments.
Funder
Deanship of Scientific Research at Al-Zaytoonah University of Jordan
Reference426 articles.
1. Pharmacogenomics of Alzheimer’s and Parkinson’s diseases;Cacabelos;Neurosci. Lett.,2020
2. Cacabelos, R., Meyyazhagan, A., Carril, J.C., Cacabelos, P., and Teijido, Ó. (2018). Pharmacogenetics of vascular risk factors in Alzheimer’s disease. J. Pers. Med., 8.
3. Have there been improvements in Alzheimer’s disease drug discovery over the past 5 years?;Cacabelos;Expert Opin. Drug Discov.,2018
4. Pharmacogenomics and therapeutic prospects in Alzheimer’s disease;Cacabelos;Expert Opin. Pharmacother.,2005
5. Pharmacogenomics of Alzheimer’s disease: Novel therapeutic strategies for drug development;Cacabelos;Methods Mol. Biol.,2014
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献